Henry Winslow

Founder of Tricycle Day 🫠

This Week in Psychedelics

Mar 4, 2026

🫠 This Week in Psychedelics

[5-min read] RAND report estimates 23% of U.S. adults support legalizing psilocybin.

Henry Winslow

Psychonaut POV

Mar 1, 2026

🫠 Psychonaut POV

[5-min read] Q&A with Josie Kins, Phenomenologist & Engineer

Henry Winslow

Ask a Guide Anything

Feb 27, 2026

🫠 Ask a Guide Anything

[3-min read] Facilitators explain how to tell if you need more medicine or more integration.

Henry Winslow

This Week in Psychedelics

Feb 25, 2026

🫠 This Week in Psychedelics

[5-min read] FDA designates luvesilocin a breakthrough therapy.

Henry Winslow

Psychonaut POV

Feb 22, 2026

🫠 Psychonaut POV

[5-min read] Q&A with Danny Motyka, Cofounder & CEO

Henry Winslow

Ask a Guide Anything

Feb 20, 2026

🫠 Ask a Guide Anything

[3-min read] Facilitators explain when group psilocybin therapy is best for the client.

Henry Winslow

This Week in Psychedelics

Feb 18, 2026

🫠 This Week in Psychedelics

[5-min read] Compass shares results from second Phase 3 psilocybin trial.

Henry Winslow

Psychonaut POV

Feb 15, 2026

🫠 Psychonaut POV

[5-min read] Q&A with Liana Gillooly, Founder & Board Member

Henry Winslow

Ask a Guide Anything

Feb 13, 2026

🫠 Ask a Guide Anything

[3-min read] Facilitators break down how psilocybin and ketamine therapy compare.

Henry Winslow

This Week in Psychedelics

Feb 11, 2026

🫠 This Week in Psychedelics

[5-min read] Pilot program brings at-home ketamine-assisted therapy to hospice patients.

Henry Winslow

Psychonaut POV

Feb 8, 2026

🫠 Psychonaut POV

[5-min read] Q&A with Skippy Mesirow, Former City Councilman

Henry Winslow

Ask a Guide Anything

Feb 6, 2026

🫠 Ask a Guide Anything

[3-min read] Facilitators comment on whether psychedelics bypass growth experiences.

Henry Winslow

This Week in Psychedelics

Feb 4, 2026

🫠 This Week in Psychedelics

[5-min read] Preclinical research shows low-dose psilocybin reverses metabolic disease.

Henry Winslow

Psychonaut POV

Feb 1, 2026

🫠 Psychonaut POV

[5-min read] Q&A with Jeremy Rudy, Founder & CEO

Henry Winslow

Ask a Guide Anything

Jan 30, 2026

🫠 Ask a Guide Anything

[3-min read] Psychedelic facilitators share practices for staying grounded when life gets chaotic.

Henry Winslow

This Week in Psychedelics

Jan 28, 2026

🫠 This Week in Psychedelics

[5-min read] RAND study projects 10 million Americans microdosed in 2025.

Henry Winslow

Psychonaut POV

Jan 25, 2026

🫠 Psychonaut POV

[5-min read] Q&A with Courtney Campbell, Founder & Facilitator

Henry Winslow

Ask a Guide Anything

Jan 23, 2026

🫠 Ask a Guide Anything

[3-min read] Psychedelic facilitators share their advice on setting intentions before a journey.

Henry Winslow

This Week in Psychedelics

Jan 21, 2026

🫠 This Week in Psychedelics

[5-min read] WHO data suggests severe adverse events from psychedelics are rare.

Henry Winslow

Psychonaut POV

Jan 18, 2026

🫠 Psychonaut POV

[5-min read] Q&A with Kylea Taylor, Therapist & Author

Henry Winslow

Ask a Guide Anything

Jan 16, 2026

🫠 Ask a Guide Anything

[3-min read] Psychedelic facilitators recommend a vetting process for picking your guide.

Henry Winslow

This Week in Psychedelics

Jan 14, 2026

🫠 This Week in Psychedelics

[5-min read] FDA accepts Compass Pathways' application to test psilocybin for PTSD.

Henry Winslow

Psychonaut POV

Jan 11, 2026

🫠 Psychonaut POV

[5-min read] Q&A with Sam Chapman, Psychedelic Policy Advisor

Henry Winslow

Ask a Guide Anything

Jan 9, 2026

🫠 Ask a Guide Anything

[3-min read] Psychedelic facilitators weigh the pros and cons of the regulated model.

Henry Winslow

This Week in Psychedelics

Jan 7, 2026

🫠 This Week in Psychedelics

[5-min read] Real-world psilocybin therapy study tempers expectations for treatment-resistant depression.

Henry Winslow